Combined use of the canine adenovirus-2 and DREADD-technology to activate specific neural pathways in vivo (Q35149585)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Combined use of the canine adenovirus-2 and DREADD-technology to activate specific neural pathways in vivo |
scientific article |
Statements
1 reference
Combined use of the canine adenovirus-2 and DREADD-technology to activate specific neural pathways in vivo (English)
1 reference
Roger A H Adan
Mieneke C M Luijendijk
15 April 2014
1 reference
15 April 2014
1 reference